Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CORT Corcept Therapeutics

24.950
+0.250+1.01%
Close 09/27 16:00 ET
24.900
-0.050-0.20%
Post Mkt Price 09/27 18:00 ET
High
25.120
Open
24.810
Turnover
12.17M
Low
24.570
Pre Close
24.700
Volume
490.26K
Market Cap
2.67B
P/E(TTM)
26.54
52wk High
29.930
Shares
107.11M
P/E(Static)
28.03
52wk Low
15.825
Float Cap
2.18B
Bid/Ask %
-90.00%
Historical High
31.180
Shs Float
87.49M
Volume Ratio
0.96
Historical Low
0.680
Dividend TTM
--
Div Yield TTM
--
P/B
6.04
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.56%
Amplitude
2.23%
Avg Price
24.832
Lot Size
1
Float Cap
2.18B
Bid/Ask %
-90.00%
Historical High
31.180
Shs Float
87.49M
Volume Ratio
0.96
Historical Low
0.680
Dividend TTM
--
P/B
6.04
Dividend LFY
--
Turnover Ratio
0.56%
Amplitude
2.23%
Avg Price
24.832
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
CEO: Dr. Joseph K. Belanoff, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...